Literature DB >> 3261235

The lack of effect of phenol red or estradiol on the growth response of human, rat, and mouse mammary cells in primary culture.

J Richards1, W Imagawa, A Balakrishnan, M Edery, S Nandi.   

Abstract

Normal and neoplastic mammary cells from both human and rodent sources grow in culture in response to a number of hormones and growth factors. However, with the exception of a few human tumor lines, a consistent growth-promoting effect of estrogens on mammary cells has not been observed. Mammary cells can be shown to respond to other hormones and factors, such as PRL, hydrocortisone, and epidermal growth factor. Recent observations suggest that the pH indicator dye phenol red, found in most media, may be masking any exogenous estrogenic effects by acting as a weak estrogen. To test this possibility, we reexamined the effects of estradiol (E2) and the antiestrogen keoxifene on the growth of normal human, mouse, and rat mammary cells in the absence of phenol red. Primary cultures of these mammary cells were grown within a rat tail collagen gel matrix in a serum-free medium made up of Ham's F-12 and Dulbecco's Modified Eagles' medium (1:1) with and without phenol red. The medium was supplemented with various hormones and growth factors. These supplements were selected for each cell type to produce a variety of conditions from nongrowing to rapidly growing. The effects of E2 (10(-10)-10(-8) M, keoxifene (10(-9)-10(-6) M), and phenol red on growth under these various conditions were examined. Phenol red had no effect on growth, and its absence did not restore a response to E2. Keoxifene, in the presence or absence of E2, also had no effect on growth. Although E2 had no effect on growth, it was able to induce a 150% increase in the progesterone receptor levels in normal mouse mammary cells in culture, indicating that the cells retain their capacity to respond to E2. This work supports the idea that the effect of estrogens on growth in vivo may be mediated through some other factor(s).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261235     DOI: 10.1210/endo-123-3-1335

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Estrogenic impurities in tissue culture plastic ware are not bisphenol A.

Authors:  Caroline Biswanger; Laura Davis; Rebecca A Roberts
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Nov-Dec       Impact factor: 2.416

2.  Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors.

Authors:  H A Hahm; M M Ip
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

3.  Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone.

Authors:  R B Clarke; A Howell; E Anderson
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Cocaine- and amphetamine-regulated transcript accelerates termination of follicle-stimulating hormone-induced extracellularly regulated kinase 1/2 and Akt activation by regulating the expression and degradation of specific mitogen-activated protein kinase phosphatases in bovine granulosa cells.

Authors:  Aritro Sen; Lihua Lv; Nora Bello; James J Ireland; George W Smith
Journal:  Mol Endocrinol       Date:  2008-09-25

5.  Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies.

Authors:  P Berthon; G Pancino; P de Cremoux; A Roseto; C Gespach; F Calvo
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

Review 6.  Mammary gland development--It's not just about estrogen.

Authors:  Grace E Berryhill; Josephine F Trott; Russell C Hovey
Journal:  J Dairy Sci       Date:  2015-10-23       Impact factor: 4.034

7.  The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis.

Authors:  Nathalie Zatula; Maria Wiese; Jens Bunzendahl; Walter Birchmeier; Christina Perske; Annalen Bleckmann; Felix H Brembeck
Journal:  Oncotarget       Date:  2014-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.